Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma
18h agoen
From the article
Conditions : Anal Squamous Cell Carcinoma, Limited-stage Interventions : Radiation: Intensity-Modulated Radiotherapy (IMRT); Drug: Capecitabine; Biological: Sintilimab; Drug: Mitomycin (MMC) Sponsors : Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting
Continue reading on clinicaltrials.govYou might also wanna read
ClinicalKey
clinicalkey.com·1mo agoReal-World EV Plus Pembro Success Seen in Urothelial Cancer
Medscape·1d ago
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
doi.org·6d ago
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
The Independent·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.